Development and assessment of an abbreviated medication regimen complexity index (the A-MRCI)

Rebekah P Scrivens1,2, Ina Liu1,2, Joshua D Niznik3,4

  • 1Department of Pharmacy, UNC Health, Chapel Hill, NC.

Abstract

Insights

An abbreviated medication regimen complexity index (A-MRCI) shows higher scores and better association with patient factors than the original MRCI. This automated tool may improve medication management and patient outcomes.

Area of Science:

  • Pharmacology and Health Services Research
  • Clinical Pharmacy and Patient Outcomes
  • Health Informatics and Electronic Health Records

Background:

  • The Medication Regimen Complexity Index (MRCI) is a tool to assess medication complexity.
  • Automating MRCI in electronic medical records (EMRs) could enhance medication optimization and patient outcomes.
  • Current MRCI adaptation for EMR automation requires evaluation.

Purpose of the Study:

  • To develop and evaluate an abbreviated medication regimen complexity index (A-MRCI).
  • To compare the associations of A-MRCI with patient-level factors against the original MRCI.
  • To assess the potential for EMR integration and automation of medication regimen complexity assessment.

Main Methods:

  • The MRCI was modified through expert panel reviews by clinical pharmacists and outcomes researchers.
  • Medication data from 138 electronic health records were used to calculate MRCI and A-MRCI scores.
  • Inferential statistics compared the indices using data from cardiology and advanced heart failure patients in 2017.

Main Results:

  • A-MRCI scores were significantly higher than MRCI scores (mean difference 3.97, P < 0.0005).
  • A-MRCI scores demonstrated significant associations with length of stay (P = 0.0005) and polypharmacy (P < 0.0005).
  • The original MRCI did not show a demonstrated association with the examined patient-level factors.

Conclusions:

  • The A-MRCI is higher on average and more strongly associated with key patient-level factors than the MRCI.
  • Internal analyses suggest the A-MRCI's potential for automated integration into electronic health records.
  • Further validation of the A-MRCI in a larger, external sample is recommended.

Related Concept Videos

Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
Three-Compartment Open Model01:06

Three-Compartment Open Model

The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
183
Two-Compartment Open Model: Extravascular Administration01:12

Two-Compartment Open Model: Extravascular Administration

The two-compartment model for extravascular administration represents a drug's absorption and distribution process. It features a central compartment, where the drug is first absorbed, and a peripheral compartment, which illustrates the drug's distribution throughout the body. The rate of change in drug concentration in the central compartment is calculated by three exponents: absorption, distribution, and elimination.
The absorption exponent (ka) indicates the speed at which the drug...
173
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
121